QL:reducte in myocardial fibrosis, promote TGF-β3/Smad7, and inhibite TGF-β1/Smad3;reverse Bax/Bcl-2 upregulation;inhibite Smad3 by upregulating miR-345-3p. Here, SMAD7 is linked to Myocardial fibrosis.